Humana Inc. (NYSE:HUM) Shares Bought by Bank of Nova Scotia

Bank of Nova Scotia raised its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 99.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,747 shares of the insurance provider's stock after buying an additional 53,802 shares during the period. Bank of Nova Scotia owned about 0.09% of Humana worth $27,336,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in HUM. FPC Investment Advisory Inc. purchased a new position in Humana in the fourth quarter valued at about $27,000. Centricity Wealth Management LLC acquired a new position in Humana during the 4th quarter worth approximately $30,000. LFA Lugano Financial Advisors SA grew its position in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock valued at $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management purchased a new stake in shares of Humana during the fourth quarter valued at approximately $33,000. Finally, Atwood & Palmer Inc. boosted its stake in shares of Humana by 64.5% in the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock valued at $39,000 after purchasing an additional 60 shares during the period. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Stock Performance

Shares of NYSE:HUM traded up $0.63 on Tuesday, hitting $285.45. The company's stock had a trading volume of 331,537 shares, compared to its average volume of 1,634,709. The company has a market capitalization of $34.45 billion, a price-to-earnings ratio of 28.69, a price-to-earnings-growth ratio of 2.05 and a beta of 0.62. The stock's 50-day moving average is $265.43 and its two-hundred day moving average is $270.11. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76.

Remove Ads

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.24%. Humana's dividend payout ratio is currently 35.58%.

Analyst Ratings Changes

A number of research firms have weighed in on HUM. Morgan Stanley decreased their price objective on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 12th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 target price on shares of Humana in a research report on Wednesday, February 12th. JPMorgan Chase & Co. dropped their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Barclays raised their price objective on shares of Humana from $270.00 to $322.00 and gave the stock an "equal weight" rating in a report on Friday. Finally, Piper Sandler lifted their price target on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Seventeen research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and a consensus price target of $284.90.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.